Table 1.
Baseline characteristics of the EPGA cohort*
| Variables | |
|---|---|
| Male | 32 (51.6%) |
| Age (y) | 48.29±15.60 |
| Asthma | 58 (93.5%) |
| Blood eosinophilia >10% | 44 (97.8%) |
| Mononeuropathy or polyneuropathy | 22 (35.5%) |
| Non-fixed pulmonary infiltrates | 35 (56.4%) |
| Paranasal sinus abnormalities | 38 (61.3%) |
| Available histology with tissue eosinophilia | 35 (56.4%) |
| Mean 5 factor score | 1.06±0.83 |
| Erythrocyte sedimentation rate (mm first hour) | 49.25±19.21 |
| C-reactive protein (mg/dL) | 17.65±32.88 |
| Leukocyte count (x1000/ µL) | 18.66±8.51 |
| Eosinophil count (x1000/ µL) | 10.11±10.02 |
| Eosinophils (% of leukocyte count) | 44.29±21.10 |
| ANCA+ | 9 (17.0%) |
| Rise of cardiac biomarkers | 48 (77.4%) |
EGPA, Eosinophilic granulomatosis with polyangiitis; ANCA, Antineutrophil cytoplasmic antibody
*
Data are presented as n (%) or mean±SD.